Unknown

Dataset Information

0

A novel specific PERK activator reduces toxicity and extends survival in Huntington's disease models.


ABSTRACT: One of the pathways of the unfolded protein response, initiated by PKR-like endoplasmic reticulum kinase (PERK), is key to neuronal homeostasis in neurodegenerative diseases. PERK pathway activation is usually accomplished by inhibiting eIF2?-P dephosphorylation, after its phosphorylation by PERK. Less tried is an approach involving direct PERK activation without compromising long-term recovery of eIF2? function by dephosphorylation. Here we show major improvement in cellular (STHdhQ111/111) and mouse (R6/2) Huntington's disease (HD) models using a potent small molecule PERK activator that we developed, MK-28. MK-28 showed PERK selectivity in vitro on a 391-kinase panel and rescued cells (but not PERK-/- cells) from ER stress-induced apoptosis. Cells were also rescued by the commercial PERK activator CCT020312 but MK-28 was significantly more potent. Computational docking suggested MK-28 interaction with the PERK activation loop. MK-28 exhibited remarkable pharmacokinetic properties and high BBB penetration in mice. Transient subcutaneous delivery of MK-28 significantly improved motor and executive functions and delayed death onset in R6/2 mice, showing no toxicity. Therefore, PERK activation can treat a most aggressive HD model, suggesting a possible approach for HD therapy and worth exploring for other neurodegenerative disorders.

SUBMITTER: Ganz J 

PROVIDER: S-EPMC7181660 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications


One of the pathways of the unfolded protein response, initiated by PKR-like endoplasmic reticulum kinase (PERK), is key to neuronal homeostasis in neurodegenerative diseases. PERK pathway activation is usually accomplished by inhibiting eIF2α-P dephosphorylation, after its phosphorylation by PERK. Less tried is an approach involving direct PERK activation without compromising long-term recovery of eIF2α function by dephosphorylation. Here we show major improvement in cellular (STHdh<sup>Q111/111  ...[more]

Similar Datasets

| S-EPMC5333955 | biostudies-literature
| S-EPMC1800909 | biostudies-literature
| S-EPMC2635561 | biostudies-literature
| S-EPMC7998230 | biostudies-literature
| S-SCDT-EMBOJ-2020-104671 | biostudies-other
| S-EPMC8421361 | biostudies-literature
| S-EPMC5717400 | biostudies-literature
| S-EPMC4741708 | biostudies-other
| S-EPMC6657616 | biostudies-literature
| S-EPMC7459410 | biostudies-literature